Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, and offers 2.0% dividend yield.

Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS. Read why I ...

Fintel reports that on October 23, 2024, Baird upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Neutral to ...

In a report released today, David S Macdonald from Truist Financial reiterated a Hold rating on Quest Diagnostics (DGX – Research ...

Q3 2024 Earnings Call Transcript October 22, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

The Gefion AI Supercomputer is Denmark's first supercomputer and will drive research on quantum computing, medicine, green ...

Check the time stamp on this data. Updated AI-Generated Signals for Quest Diagnostics Incorporated (DGX) available here: DGX.

India's Sify Technologies has launched a GPU cloud offering. The ICT solutions provider is now offering its GPU as a Service ...

Quest Diagnostics Incorporated’s DGX third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted ...

Technical analysis for Quest Diagnostics Incorporated DGX including support levels resistance levels and stop losses for DGX ...

Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.22 per share a year ago.